Idea of the Day: Lift Restrictions on Federal Stem Cell Funding
It is time for the United States to stake its claim as the world leader in regenerative medicine, which promises to become a vital component of the cutting edge of life sciences research and innovation in the 21st century. To ensure research in this newly emerging field of life sciences is conducted responsibly and ethically, the federal government must reform its stem cell research policy in order to fund embryonic stem cell research that is robust and comprehensive as well as cautious and principled.
The first step toward renewing U.S. life sciences leadership must be taken by the executive branch. President Barack Obama has the option of either issuing an executive order or issuing a presidential memorandum to govern stem cell research. Either way, the primary objective of the executive document must be to lift the existing temporal restriction on the federal funding of embryonic stem cell research.
Currently, federal funding is only available for research on the 21 lines of embryonic stem cells that were derived before August 9, 2001. Once this arbitrary limit is lifted, the National Institutes of Health would be able to issue grants to scientists who wish to research embryonic stem cells in accordance with ethical guidelines.
For more on this topic, please see:
- A Life Sciences Crucible: Stem Cell Research Done Responsibly and Ethically by Michael Rugnetta and Michael Peroski
To speak with our experts on this topic, please contact:
Print: Suzi Emmerling (foreign policy and security, energy, education, immigration)
202.481.8224 or semmerling@americanprogress.org
Print: Jason Rahlan (health care, economy, civil rights, poverty)
202.481.8132 or jrahlan@americanprogress.org
Radio: John Neurohr
202.481.8182 or jneurohr@americanprogress.org
TV: Andrea Purse
202.741.6250 or apurse@americanprogress.org
Web: Erin Lindsay
202.741.6397 or elindsay@americanprogress.org